Potential use of biochemical markers of bone turnoverfor assessing the effect of calcium supplementation and predicting fracture risk

Clinical Therapeutics

Volumn 27, Issue 3, 2005, Pages 299-308

  Weisman, Steven M ^a   Matkovic, Velimir ^b  

^a Innovative Science Solutions   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Bone biomarkers; Calcium supplements; Fracture risk; Osteoporosis; Review

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; BIOLOGICAL MARKER; CALCIUM; CALCIUM CARBONATE; CALCIUM LACTATE; CALCIUM PHOSPHATE; CALCIUM SALT; CITRATE CALCIUM; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; GLUCONIC ACID; HYDROXYAPATITE; HYDROXYPROLINE; MALIC ACID DERIVATIVE; MATRIX PROTEIN; OSTEOCALCIN; PHOSPHATASE; PROCOLLAGEN; PROCOLLAGEN C PROTEINASE; PYRIDINOLINE; TELOPEPTIDE; VITAMIN D;

BONE DENSITY; BONE REMODELING; BONE TURNOVER; CLINICAL TRIAL; COMPARATIVE STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; FRACTURE; HUMAN; HYDROXYPROLINE URINE LEVEL; MEDLINE; ORANGE JUICE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PREDICTION; PUBLICATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; TREATMENT OUTCOME;

EID: 18844414587     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.dinthera.2005.03.003     Document Type: Article

References (41)

1. Bone Health and Osteoporosis: A Surgeon General's Report 2004 US Dept of Health and Human Services Washington, DC
2. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride (DRI) 1997 National Academies Press Washington, DC
3. Sunyecz JA, Weisman SM, Calcium's role in osteoporosisdrug therapy. J Womens Health. In press.
4. Baran D.T. Osteoporosis: Which current treatments reduce fracture risk? Cleve Clin J Med. 67 2000 701 703
5. International Osteoporosis Foundation [press release].Bone mineral density confirmed as key indicator of fracture risk. Available at: http://www.osteofound.org/wco/2004/press_releases_files/pr_2004_05_16c.pdf. Accessed April 10, 2004.
6. [Epub ahead of print] Kanis J.A., Borgstrom F., and De Laet C. Assessment of fracture risk Osteoporos Int. 2004
7. Khosla S., and Kleerekoper M. Biochemical markers of bone turnover Favus M.J. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 5th ed. 2003 American Society for Bone and Mineral Research Washington, DC: 166 172
8. Garnero P., Shih W.J., and Gineyts E. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment J Clin Endocrinol Metab. 79 1994 1693 1700
9. Riggs B.L., Melton L.J. III, and O'Fallon W.M. Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy Bone 18 Suppl 3 1996 197S 201S
10. Kamel S., Fardellone P., and Meddah B. Response of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake Clin Chem. 44 1998 1437 1442
11. Akesson K., Lau K.H., and Johnston P. Effects of shortterm calcium depletion and repletion on biochemical markers of bone turnover in young adult women J Clin Endocrinol Metab. 83 1998 1921 1927
12. Kenny A.M., Prestwood K.M., and Biskup B. Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal women Osteoporos Int. 15 2004 290 294
13. Eastell R., Barton I., and Hannon R.A. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate J Bone Miner Res. 18 2003 1051 1056
14. van Daele P.L., Seibel M.J., and Burger H. Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam Study BMJ 312 1996 482 483
15. Tromp A.M., Ooms M.E., and Popp-Snijders C. Predictors of fractures in elderly women Osteoporos Int. 11 2000 134 140
16. Vergnaud P., Garnero P., and Meunier P.J. Undercarboxylated osteocalcin measured with a specific immuno assay predicts hip fracture in elderly women: The EPIDOS Study J Clin Endocrinol Metab. 82 1997 719 724
17. Garnero P., Sornay-Rendu E., Claustrat B., and Delmas P.D. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY Study J Bone Miner Res. 15 2000 1526 1536
18. Fardellone P., Brazier M., and Kamel S. Biochemical effects of calcium supplementation in postmenopausal women: Influence of dietary calcium intake Am J Clin Nutr. 67 1998 1273 1278
19. Ginty F., Flynn A., and Cashman K.I.D. The effect of short-term calcium supplementation on biochemical markers of bone metabolism in healthy young adults Br J Nutr. 80 1998 437 443
20. Zikan V., Haas T., and Stepan J.J. Acute effects in healthy women of oral calcium on the calcium-parathyroid axis and bone resorption as assessed by serum beta-CrossLaps Calcif Tissue Int. 68 2001 352 357
21. Hannon R.A., and Eastell R. Biochemical markers of bone turnover and fracture prediction J Br Menopause Soc. 9 2003 10 15
22. Greenspan S.L., Parker R.A., and Ferguson L. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: A randomized clinical trial J Bone Miner Res. 13 1998 1431 1438
23. Green JH. Biochemical markers: Clinical and research applications for biochemical markers of bone turnover. Available at: http://www.newzealandmilk. com/events/nzm_sym_abstracts.html. Accessed December 23, 2004.
24. Albertazzi P., Steel S.A., Howarth E.M., and Purdie D.W. Comparison of the effects of two different types of calcium supplementation on markers of bone metabolism in a postmenopausal osteopenic populationwith low calcium intake: A double-blind placebo-controlled trial Climacteric. 7 2004 33 40
25. Bauer D.C., Black D., and Ensrud K. Upper gastrointestinal tract safety profile of alendronate: The Fracture Intervention Trial Arch Intern Med. 160 2000 517 525
26. Garnero P., Hausherr E., and Chapuy M.C. Markers of bone resorption predict hip fracture in elderlywomen: The EPIDOS Prospective Study J Bone Miner Res. 11 1996 1531 1538
27. Rosen C.J., Chesnut C.H. III, and Mallinak N.J. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation J Clin Endocrinol Metab. 82 1997 1904 1910
28. Martini L., and Wood R.J. Relative bioavailability of calcium-rich dietary sources in the elderly Am J Clin Nutr. 76 2002 1345 1350
29. Riggs B.L., O'Fallon W.M., and Muhs J. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women J Bone Miner Res. 13 1998 168 174
30. Szulc P., Chapuy M.C., Meunier P.J., and Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the riskof hip fracture: A three year followup study Bone 18 1996 487 488
31. Abstract Weel A.E., Seibel M.J., and Hofman A. Which fractures are associated with high bone resorption in elderly women: The Rotterdam Study J Bone Miner Res. 14 Suppl 1 1999 S160
32. Ross P.D., Kress B.C., and Parson R.E. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: A prospective study Osteoporos Int. 11 2000 76 82
33. Chapurlat R.D., Garnero P., and Breart G. Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: The EPIDOS Study Bone 27 2000 283 286
34. Plantalech L., Guillaumont M., and Vergnaud P. Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women J Bone Miner Res. 6 1991 1211 1216
35. Recker R.R. Calcium absorption and achlorhydria N Engl J Med. 313 1985 70 73
36. Prestwood K.M., Thompson D.L., and Kenny A.M. Low dose estrogen and calcium have an additive effect on bone resorption in older women J Clin Endocrinol Metab. 84 1999 179 183
37. Heaney R.P., Dowell S.I.D., and Bierman J. Absorbability and cost effectiveness in calcium supplementation J Am Coll Nutr. 20 2001 239 246
38. Grados F., Brazier M., and Kamel S. Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation J Clin Endocrinol Metab. 88 2003 5175 5179
39. Sheikh M.S., Santa Ana C.A., and Nicar M.J. Gastrointestinal absorption of calcium from milk and calcium salts N Engl J Med. 317 1987 532 536
40. Deroisy R., Zartarian M., and Meurmans L. Acute changes in serum calcium and parathyroid hormone circulating levels induced by the oral intake of five currently available calcium salts inhealthy male volunteers Clin Rheumatol. 16 1997 249 253
41. Dawson-Hughes B., Dallal G.E., and Krall E.A. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women N Engl J Med. 323 1990 873 883